Columnar Epithelial Stem Cell Culture for Expansion Without Losing Immaturity

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods are limited in isolating and maintaining the immaturity of columnar epithelial stem cells, particularly from diseased tissues, which are crucial for regenerative medicine and cancer therapy, due to challenges in cloning and expanding these cells while preserving their in vivo characteristics.

Innovation Solution

A culture system using a combination of ROCK inhibitor, Wnt agonist, mitogenic growth factor, insulin or IGF, BRAF inhibitor, and VEGF inhibitor, optionally with additional factors like Notch agonist and extracellular matrix, to isolate and expand columnar epithelial stem cells, maintaining their epigenetic memory and immaturity.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Productivity

If conventional cloning methods are used to expand stem cells, then cell quantity increases, but the immaturity and in vivo characteristics of columnar epithelial stem cells are lost

Engineering Contradiction:
Improvecell expansion capabilityVSAvoidimmaturity of stem cells
Core Design Contradiction:
ProductivityVSStability of the object's composition

Solution Approach 1:

The invention changes the chemical parameters of the culture medium by incorporating specific small molecules (ROCK inhibitor, Wnt agonist, mitogenic growth factor, insulin/IGF, BRAF inhibitor, VEGF inhibitor) that collectively maintain stem cell immaturity while enabling expansion. This parameter change in the culture environment resolves the contradiction between expanding cell numbers and preserving cellular characteristics.

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The small molecules act as intermediaries between the culture system and the stem cells, mediating the maintenance of immaturity during expansion. These molecules translate the requirement for both cell proliferation and characteristic preservation into a workable culture protocol.

Inventive Principle:
Principle #24Intermediary (Mediator)

2Ease of manufacture

If stem cells from diseased tissues are isolated using conventional methods, then isolation is attempted, but the cells fail to maintain their regenerative capacity and in vivo characteristics

Engineering Contradiction:
Improveisolation process feasibilityVSAvoidregenerative capacity of isolated cells
Core Design Contradiction:
Ease of manufactureVSReliability

Solution Approach 1:

The invention modifies the culture medium parameters with specific small molecules that create an environment capable of maintaining regenerative capacity. This parameter change enables reliable isolation and maintenance of stem cells from diseased tissues, overcoming the limitations of conventional methods.

Inventive Principle:
Principle #35Parameter changes

3Reliability

If organoids are used instead of cloned stem cells, then regenerative capacity is maintained, but the kinetics of propagation and utility for studying elemental stem cells are limited

Engineering Contradiction:
Improveregenerative capacityVSAvoidpropagation kinetics
Core Design Contradiction:
ReliabilityVSProductivity

Solution Approach 1:

The invention changes the culture parameters to enable clonal expansion while maintaining stem cell characteristics. This allows individual stem cells to be isolated and expanded with high propagation kinetics, overcoming the slow propagation limitation of organoid-based approaches while preserving regenerative capacity.

Inventive Principle:
Principle #35Parameter changes

Data Source

PatentUS12351822B2Stem cell culture systems for columnar epithelial stem cells, and uses related thereto
Publication Date: 2025.07.08 UNIV HOUSTON SYST
  • US12351822B2 patent drawing
  • US12351822B2 patent drawing
  • US12351822B2 patent drawing

AI summary

The present invention relates to a culture media system that useful for the isolation and epigenetically stable propagation of normal stem cells in culture which are derived from columnar epithelial tissues and cancer stem cells from epithelial cancers. In certain embodiments, the culture system is a feeder-free system.